Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))

Chao Feng Lin, Han Li Huang, Chieh Yu Peng, Yu Ching Lee, Hui Po Wang, Che Ming Teng, Shiow Lin Pan

Research output: Contribution to journalComment/debate

Abstract

The authors regret that an incorrect description of the author's affiliation “a” has to be revised. The correct description of affiliation “a” is: Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Article number114858
JournalToxicology and Applied Pharmacology
Volume387
DOIs
Publication statusPublished - Jan 15 2020

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint Dive into the research topics of 'Corrigendum to: TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis “Toxicol Appl Pharmacol. 2016;305:194–202” (Toxicology and Applied Pharmacology (2016) 305 (194–202)(S0041008X16301478)(10.1016/j.taap.2016.06.013))'. Together they form a unique fingerprint.

  • Cite this